Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 44, 2015 - Issue 4
132
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Antigen-Specific Killer Polylactic-Co-Glycolic Acid (PLGA) Microspheres Can Prolong Alloskin Graft Survival in a Murine Model

, , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Khawar Ali Shahzad, Muhammad Naeem, Lei Zhang, Xin Wan, Shilong Song, Weiya Pei, Chen Zhao, Xiaoxiao Jin & Chuanlai Shen. (2020) Design and Optimization of PLGA Particles to Deliver Immunomodulatory Drugs for the Prevention of Skin Allograft Rejection. Immunological Investigations 49:7, pages 840-857.
Read now

Articles from other publishers (3)

Madonna Rica Anggelia, Ren-Wen Huang, Hui-Yun Cheng, Chih-Hung Lin & Cheng-Hung Lin. (2022) Implantable Immunosuppressant Delivery to Prevent Rejection in Transplantation. International Journal of Molecular Sciences 23:3, pages 1592.
Crossref
Wei Wang, Khawar Ali Shahzad, Miaochen Li, Aifeng Zhang, Lei Zhang, Tao Xu, Xin Wan & Chuanlai Shen. (2017) An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8+ T Cells. Frontiers in Immunology 8.
Crossref
Betty Tyler, David Gullotti, Antonella Mangraviti, Tadanobu Utsuki & Henry Brem. (2016) Polylactic acid (PLA) controlled delivery carriers for biomedical applications. Advanced Drug Delivery Reviews 107, pages 163-175.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.